CLINICAL_TRIALS
trial_result
· 2021-08-12
Clinical Trial Update: PLX3397 KIT in Acral aNd mucOsal Melanoma [Phase 2]
Summary
Phase 2 trial update for PLX3397 (KIT inhibitor) in acral and mucosal melanoma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The Christie NHS Foundation Trust | Conditions: Malignant Melanoma | Phase 2 | Status: COMPLETED